Galantamine and serious skin reactions

Serious skin reactions have occurred in patients taking the Alzheimer's disease treatment galantamine (Reminyl), the manufacturer has stated in a letter to healthcare professionals

Five cases of serious skin reactions, including Stevens-Johnson syndrome (SJS), acute generalised exanthematous pustulosis (AGEP) and erythema multiforme have been reported in patients taking galantamine.

Patients being treated with the drug should be advised to discontinue treatment and seek medical help immediately if any of the following symptoms occur:

  • Severe rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (SJS)
  • Red rash covered with small pus-filled bumps that can spread over the body, sometimes with a fever (AGEP)
  • Rash that may blister, with spots that look like small targets (erythema multiforme)

All serious suspected adverse reactions associated with galantamine should be reported in accordance with the MHRA Yellow Card Scheme.

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.